Myeloid-derived-suppressor cells as regulators of the immune system

Gabrilovich, Dmitry I., Nagaraj, Srinivas·2009·Nature Reviews Immunology

Cited by (1,052)

Items 401–500 of 1,052

  1. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
    Anil Kumar, Adeleh Taghi Khani, Ashly Sanchez Ortiz, Srividya Swaminathan · 2022 · Frontiers in Immunology
  2. Cancer Inflammation and Cytokines
    Maria Rosaria Galdiero, Gianni Marone, Alberto Mantovani · 2017 · Cold Spring Harbor Perspectives in Biology
  3. Proinflammatory role of epithelial cell–derived exosomes in allergic airway inflammation
    Ankur Kulshreshtha, Tanveer Ahmad, Anurag Agrawal, Balaram Ghosh · 2013 · Journal of Allergy and Clinical Immunology
  4. CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
    Michelle Gleason, Julie A. Ross, Erica Dahl Warlick, Troy C. Lund, Michael R. Verneris, Andres Wiernik, Stephen R. Spellman, Michael D. Haagenson, Alexander J. Lenvik, Mark Robert Litzow et al. · 2014 · Blood
  5. Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
    Lifeng Li, Liping Wang, Jieyao Li, Zhirui Fan, Yang Li, Zhen Zhang, Chaoqi Zhang, Dongli Yue, Guohui Qin, Tengfei Zhang et al. · 2018 · Cancer Research
  6. Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
    Anqi Lin, Ting Wei, Hui Meng, Peng Luo, Jian Zhang · 2019 · Molecular Cancer
  7. Immune defence to invasive fungal infections: A comprehensive review
    Balaji Pathakumari, Guanzhao Liang, Weida Liu · 2020 · Biomedicine & Pharmacotherapy
  8. MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
    Takashi Kimura, John McKolanis, Lynda Ann. Dzubinski, Kazi Islam, Douglas M. Potter, Andres Μ. Salazar, Robert E. Schoen, Olivera J. Finn · 2012 · Cancer Prevention Research
  9. Inflammation: A driving force speeds cancer metastasis
    Wu, Yadi, Zhou, Binhua P. · 2009 · Cell Cycle
  10. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
    Xinyu Tian, Han Shen, Zhiyang Li, Tingting Wang, Shengjun Wang · 2019 · Journal of Hematology & Oncology
  11. Mesenchymal stromal cells and the innate immune response
    Katarina Le Blanc, Lindsay C. Davies · 2015 · Immunology Letters
  12. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Jiawen Qian, Chen Wang, Bo Wang, Jiao Yang, Yuedi Wang, Feifei Luo, Junying Xu, Chujun Julia Zhao, Ronghua Liu, Yiwei Chu · 2018 · Journal of Neuroinflammation
  13. Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
    Sergey V. Ryzhov, Sergey V. Novitskiy, Anna E. Goldstein, Asel Biktasova, Michael R. Blackburn, Italo Biaggioni, Mikhail M. Dikov, Igor Feoktistov · 2011 · The Journal of Immunology
  14. Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells
    Benjamin Weide, Alexander Martens, Henning Zelba, Christina Stutz, Evelyna Derhovanessian, Anna Maria Di Giacomo, Michele Maio, Antje Sucker, Bastian Schilling, Dirk Schadendorf et al. · 2013 · Clinical Cancer Research
  15. S100A8 and S100A9: New Insights into Their Roles in Malignancy
    Geetha Srikrishna · 2011 · Journal of Innate Immunity
  16. Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs
    Merav E. Shaul, Liran Levy, Jing Sun, Inbal Mishalian, Sunil Kumar Singhal, Veena Kapoor, Wen-Hwai Horng, Gil Fridlender, Steven Μ. Albelda, Zvi Gregorio Fridlender · 2016 · OncoImmunology
  17. Regulation of Inflammation- and Infection-Driven Hematopoiesis
    Steffen Boettcher, Markus Gabriel Manz · 2017 · Trends in Immunology
  18. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
    Qianfei Zhang, Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P. Diggs, Lichun Ma, Soumen Roy, Qiong Fu, Zachary J. Brown et al. · 2020 · Cancer Discovery
  19. Emerging Tim-3 functions in antimicrobial and tumor immunity
    Kaori Sakuishi, Pushpa Jayaraman, Samuel M. Behar, Ana Carrizosa Anderson, Vijay Kumar Kuchroo · 2011 · Trends in Immunology
  20. Determinants of metastatic competency in colorectal cancer
    Daniele V. F. Tauriello, Alexandre Calon, Enza Lonardo, Eduard Batlle · 2017 · Molecular Oncology
  21. Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma
    Geoffrey Thomas Gibney, Ragini Reiney Kudchadkar, Ronald C. DeConti, Melissa S. Thebeau, Maria P. Czupryn, Leticia F. Tetteh, Cabell E. Eysmans, Allison D. Richards, Michael J. Schell, Kate J. Fisher et al. · 2014 · Clinical Cancer Research
  22. Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
    Nathan L. Bowers, Eric Scott Helton, Richard P. H. Huijbregts, Paul Goepfert, Sonya L. Heath, Zdeněk Hel · 2014 · PLoS Pathogens
  23. Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
    Yuko Shirota, Hidekazu Shirota, Dennis M. Klinman · 2012 · The Journal of Immunology
  24. Macroscale biomaterials strategies for local immunomodulation
    Maxence O. Dellacherie, Bo Ri Seo, David J. Mooney · 2019 · Nature Reviews Materials
  25. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
    Robin Parihar, Charlotte Helena Rivas, Mai Huynh, Bilal A. Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen M Gottschalk, Cliona M. Rooney · 2019 · Cancer Immunology Research
  26. Pre-metastatic niche: formation, characteristics and therapeutic implication
    Yuhang Wang, Jiachi Jia, Fuqi Wang, Yingshuai Fang, Yabing Yang, Quanbo Zhou, Weitang Yuan, Xiaoming Gu, Junhong Hu, Shuaixi Yang · 2024 · Signal Transduction and Targeted Therapy
  27. Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
    Sid P. Kerkar, Pawel J. Muranski, Andrew Kaiser, Andrea Boni, Luis A Sanchez-Perez, Zhiya Yu, Douglas C. Palmer, Robert N. Reger, Zachary A. Borman, Ling Zhang et al. · 2010 · Cancer Research
  28. Homeostatic and pathogenic extramedullary hematopoiesis
    Chang H. Kim · 2010 · Journal of Blood Medicine
  29. Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
    Fumitaka Arihara, Eishiro Mizukoshi, Masaaki Kitahara, Yoshiko Takata, Kuniaki Arai, Tatsuya Yamashita, Yasunari Nakamoto, Shuichi Kaneko · 2013 · Cancer Immunology Immunotherapy
  30. Metabolic regulation of macrophage phenotype and function
    Shilpi Saha, Irina N. Shalova, Subhra Kumar Biswas · 2017 · Immunological Reviews
  31. Cancer Stemness Meets Immunity: From Mechanism to Therapy
    Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, Yan Xia, Ronald Anthony DePinho · 2021 · Cell Reports
  32. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
    Regina Jitschin, Martina Braun, Maike Büttner, Katja Dettmer‐Wilde, Juliane Bricks, Jana Berger, Michael Josef Eckart, Stefan W. Krause, Peter Josef Oefner, Katarina Le Blanc et al. · 2014 · Blood
  33. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
    S. Ferrari, P. Fallahi, M. Galdiero, I. Ruffilli, G. Elia, F. Ragusa, S. R. Paparo, Armando Patrizio, V. Mazzi, G. Varricchi et al. · 2019 · International Journal of Molecular Sciences
  34. Aging and cancer: The role of macrophages and neutrophils
    Jackaman, Connie, Tomay, Federica, Duong, Lelinh, Abdol Razak, Norbaini Bintu, Pixley, Fiona J., Metharom, Pat, Nelson, Delia J. · 2017 · Ageing Research Reviews
  35. Identification of Myeloid Cell Subsets in Murine Lungs Using Flow Cytometry
    Rinat Zaynagetdinov, Taylor P. Sherrill, Peggy L. Kendall, Brahm H. Segal, Kevin P. Weller, Robert M. Tighe, Timothy S. Blackwell · 2013 · American Journal of Respiratory Cell and Molecular Biology
  36. Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
    Linda Wang, Esther Wei Yin Chang, Siew Cheng Wong, Siew‐Min Ong, Debra Q. Y. Chong, Khoon Lin Ling · 2012 · The Journal of Immunology
  37. Nrf2 Prevents Initiation but Accelerates Progression through the Kras Signaling Pathway during Lung Carcinogenesis
    Hironori Satoh, Takashi Moriguchi, Jun Takai, Masahito Ebina, Masayuki P. Yamamoto · 2013 · Cancer Research
  38. VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
    Yueshui Zhao, Sipeng Guo, Jian Min Deng, Jing Shen, Fukuan Du, Xu Wu, Yu Chen, Mingxing Li, Meijuan Chen, Xiaobing Li et al. · 2022 · International Journal of Biological Sciences
  39. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy
    Liangliang Wang, Xiaoyang Dou, Shijie Chen, Xianbin Yu, Xiaona Huang, Linda Zhang, Yantao Chen, Jiaai Wang, Kaiting Yang, Jason Bugno et al. · 2023 · Cancer Cell
  40. Chemoimmunotherapy: Reengineering Tumor Immunity
    Chen, Gang, Emens, Leisha A. · 2013 · Cancer Immunology, Immunotherapy
  41. Natural and Induced T Regulatory Cells in Cancer
    Dennis O. Adeegbe, Hiroyoshi Nishikawa · 2013 · Frontiers in Immunology
  42. Once a Treg, always a Treg?
    Deepali V. Sawant, Dario A.A. Vignali · 2014 · Immunological Reviews
  43. Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
    Alexandra Sevko, Tillmann Michels, Melissa Vrohlings, Ludmila Umansky, Philipp Beckhove, Masashi Kato, Galina V. Shurin, Michael R. Shurin, Viktor Umansky · 2013 · The Journal of Immunology
  44. Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
    Jeremy D. Waight, Qiang Hu, Austin Miller, Song Liu, Scott I. Abrams · 2011 · PLoS ONE
  45. How Neutrophils Shape Adaptive Immune Responses
    Pieter H. C. Leliefeld, Leo Koenderman, Janesh Pillay · 2015 · Frontiers in Immunology
  46. Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Perspectives
    Braeden Medeiros, Alison L. Allan · 2019 · International Journal of Molecular Sciences
  47. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
    Chiu, David Kung‐Chun, Xu, Iris Ming‐Jing, Lai, Robin Kit‐Ho, Tse, Aki Pui‐Wah, Wei, Larry Lai, Koh, Hui‐Yu, Li, Lynna Lan, Lee, Derek, Lo, Regina Cheuk‐Lam, Wong, Chun‐Ming et al. · 2016 · Hepatology
  48. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
    Jian Li, Wenwen Li, Kejia Huang, Yang Zhang, Gary M. Kupfer, Qi Zhao · 2018 · Journal of Hematology & Oncology
  49. Chemical Design of Activatable Photoacoustic Probes for Precise Biomedical Applications
    Yongchao Liu, Lili Teng, Baoli Yin, Hong‐Min Meng, Xia Yin, Shuangyan Huan, Guosheng Song, Xiaobing Zhang · 2022 · Chemical Reviews
  50. Nitric Oxide Production by Myeloid Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
    Stiff, Andrew, Trikha, Prashant, Mundy-Bosse, Bethany, McMichael, Elizabeth, Mace, Thomas A., Benner, Brooke, Kendra, Kari, Campbell, Amanda, Gautam, Shalini, Abood, David et al. · 2018 · Clinical Cancer Research
  51. The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects
    Maryam Zamanian-Daryoush, Daniel J. Lindner, Thomas C. Tallant, Zeneng Wang, Jennifer A. Buffa, Elizabeth Klipfell, Yvonne Parker, Denise A. Hatala, Patricia A. Parsons‐Wingerter, Pat A. Rayman et al. · 2013 · Journal of Biological Chemistry
  52. IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
    Heth Roderick Turnquist, Zhenlin Zhao, Brian R. Rosborough, Quan Liu, Antonino Castellaneta, Kumiko Isse, Zhiliang Wang, Megan A. Lang, Donna Beer Stolz, Xin Xiao Zheng et al. · 2011 · The Journal of Immunology
  53. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis
    Fabrice Uhel, Imane Azzaoui, Murielle Grégoire, Céline Pangault, Joëlle Dulong, Jean‐Marc Tadié, Arnaud Gacouin, Christophe Camus, Luc Cynober, Thierry Fest et al. · 2017 · American Journal of Respiratory and Critical Care Medicine
  54. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis
    Jonathan S. Boomer, Jennifer Shuherk-Shaffer, Richard S. Hotchkiss, Jonathan M. Green · 2012 · Critical Care
  55. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
    Sunil Kumar Singhal, Jason E. Stadanlick, Michael J. Annunziata, Abhishek S. Rao, Pratik Sanjivkumar Bhojnagarwala, Shaun O’Brien, Edmund K. Moon, Edward Cantu, Gwenn A. Danet-Desnoyers, Hyun-Jeong Ra et al. · 2019 · Science Translational Medicine
  56. Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
    Xin Gao, Xuefeng Wang, Qianting Yang, Xin Zhao, Wen Wen, Gang Li, Junfeng Lu, Wenxin Qin, Yuan Qi, Fang Xie et al. · 2014 · The Journal of Immunology
  57. The immune system and inflammation in breast cancer
    Xinguo Jiang, David J. Shapiro · 2013 · Molecular and Cellular Endocrinology
  58. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
    Paola Filipazzi, Veronica Huber, Licia Rivoltini · 2011 · Cancer Immunology Immunotherapy
  59. How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
    Stultz, Jacob, Fong, Lawrence · 2021 · Prostate Cancer and Prostatic Diseases
  60. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
    Gañán-Gómez, I, Wei, Y, Starczynowski, D T, Colla, S, Yang, H, Cabrero-Calvo, M, Bohannan, Z S, Verma, A, Steidl, U, Garcia-Manero, G · 2015 · Leukemia
  61. In vivo discovery of immunotherapy targets in the tumour microenvironment
    Zhou, Penghui, Shaffer, Donald R., Alvarez Arias, Diana A., Nakazaki, Yukoh, Pos, Wouter, Torres, Alexis J., Cremasco, Viviana, Dougan, Stephanie K., Cowley, Glenn S., Elpek, Kutlu et al. · 2014 · Nature
  62. HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
    Katherine H. Parker, Pratima Sinha, Lucas A. Horn, Virginia K. Clements, Huan Yang, Jianhua Li, Kevin J. Tracey, Suzanne Ostrand‐Rosenberg · 2014 · Cancer Research
  63. Myeloid‐derived suppressor cell activation by combined LPS and IFN‐γ treatment impairs DC development
    Verena Greifenberg, Eliana Ribechini, Susanne Rößner, Manfred Bernhard Lutz · 2009 · European Journal of Immunology
  64. Combinations of Immunotherapy and Radiation in Cancer Therapy
    Ralph E. Vatner, Benjamin Thomas Cooper, Claire Vanpouille‐Box, Sandra Demaria, Silvia Chiara Formenti · 2014 · Frontiers in Oncology
  65. Immune checkpoints in the tumor microenvironment
    Salman M. Toor, Varun Sasidharan Nair, Julie V. Decock, Eyad Elkord · 2019 · Seminars in Cancer Biology
  66. Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
    Verschoor, Chris P, Johnstone, Jennie, Millar, Jamie, Dorrington, Michael G, Habibagahi, Mojtaba, Lelic, Alina, Loeb, Mark, Bramson, Jonathan L, Bowdish, Dawn M E · 2013 · Journal of Leukocyte Biology
  67. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans
    Chunjian Qi, Yihua Cai, Lacey Gunn, Chuanlin Ding, Bing Li, Goetz Hans Kloecker, Keqing Qian, John P. Vasilakos, Shinobu Saijo, Yoichiro Iwakura et al. · 2011 · Blood
  68. The Tumor Microenvironment in Colorectal Carcinogenesis
    Vijay G. R. Peddareddigari, Dingzhi Wang, Raymond N. DuBois · 2010 · Cancer Microenvironment
  69. CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
    Christine Zoglmeier, Helen Bauer, Daniel Noerenberg, Georg Wedekind, Philipp Max Bittner, Nadja Sandholzer, Moritz Rapp, David Anz, Stefan Endres, Carole Bourquin · 2011 · Clinical Cancer Research
  70. NF-kappaB: Two Sides of the Same Coin
    Bruno Ricardo Barreto Pires, Rafael Cardoso Maciel Costa Silva, Gerson Moura Ferreira, Eliana S. F. W. Abdelhay · 2018 · Genes
  71. Chimeric antigen receptor T-cell therapy for solid tumors
    Kheng Newick, Edmund K. Moon, Steven Μ. Albelda · 2016 · Molecular Therapy — Oncolytics
  72. Trial watch
    Laura Senovilla, Erika Vacchelli, Jérôme Galon, Sandy Adjemian, Alexander M.M. Eggermont, Wolf H. Fridman, Catherine Sautès‐Fridman, Yuting Ma, Éric Tartour, Laurence Zitvogel et al. · 2012 · OncoImmunology
  73. Gold nanoparticle mediated cancer immunotherapy
    Joao Paulo Mattos Almeida, Elizabeth Raquel Figueroa, Rebekah Anna Drezek · 2013 · Nanomedicine Nanotechnology Biology and Medicine
  74. Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
    Ahmad A. Tarhini · 2013 · Scientifica
  75. The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
    Valeria Governa, Emanuele Trella, Valentina Mele, Luigi Tornillo, Francesca Amicarella, Eleonora Cremonesi, Manuele Giuseppe Muraro, Hui Xu, Raoul Andre Droeser, Silvio Däster et al. · 2017 · Clinical Cancer Research
  76. Natural Killer T Cells in Cancer Immunotherapy
    Shiny Nair, Madhav V. Dhodapkar · 2017 · Frontiers in Immunology
  77. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
    Hailong Tian, Jiangjun Cao, Bowen Li, Edouard Collins Nice, Haijiao Mao, Yi Zhang, Canhua Huang · 2023 · Bone Research
  78. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
    Hong Qin, Beatrisa Lerman, Ippei Sakamaki, Guo‐Wei Wei, Soungchul C Cha, Sheetal S. Rao, Jianfei Qian, Yared Hailemichael, Roza Nurieva, Karen Clise Dwyer et al. · 2014 · Nature Medicine
  79. STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
    Dinesh Chandra, Wilber Quispe‐Tintaya, Arthee Jahangir, Denise A. Asafu-Adjei, Ilyssa Ramos, Herman O. Sintim, Jie Zhou, Yoshihiro Hayakawa, David K.R. Karaolis, Claudia Gravekamp · 2014 · Cancer Immunology Research
  80. The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
    Peter J. Kahrilas, Guy E. Boeckxstaens · 2013 · Gastroenterology
  81. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
    Torsten Hartwig, Antonella Montinaro, Silvia von Karstedt, Alexandra Sevko, Silvia Šurinová, Ankur Chakravarthy, Lucia Taraborrelli, Peter Dráber, Élodie Lafont, Frederick Arce Vargas et al. · 2017 · Molecular Cell
  82. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
    Haiping Wang, Fabien Franco, Ping‐Chih Ho · 2017 · Trends in cancer
  83. Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
    Ha Thi Thu Do, Chang Hoon Lee, Jungsook Cho · 2020 · Cancers
  84. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
    Gang Xu, Furong Qi, Hanjie Li, Qianting Yang, Haiyan Wang, Xin Wang, Xiaoju Liu, Juanjuan Zhao, Xuejiao Liao, Yang Liu et al. · 2020 · Cell Discovery
  85. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
    Shuyan He, Lu Zheng, Chunjian Qi · 2025 · Molecular Cancer
  86. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells
    Xiang Dong Yang, Walden Ai, Samuel Asfaha, Govind Bhagat, Richard A. Friedman, Guangchun Jin, Heuijoon Park, Benjamin Shykind, Thomas G. Diacovo, András Falus et al. · 2010 · Nature Medicine
  87. Engineering universal cells that evade immune detection
    Robert Lanza, David W. Russell, András Nagy · 2019 · Nature reviews. Immunology
  88. Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer
    Fei Wang, Jie Long, Liang Li, Zixin Wu, Tian-Tian Da, Xiaoqing Wang, Chuan Huang, Yihua Jiang, Xueqing Yao, Haiqing Ma et al. · 2023 · Science Advances
  89. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression
    Jinheng Wang, Kim De Veirman, Sylvia Faict, Maria Antonia Frassanito, Doménico Ribatti, Angelo Vacca, Eline Menu · 2016 · The Journal of Pathology
  90. On the origin of myeloid-derived suppressor cells
    Camilla Rydberg Millrud, Caroline Bergenfelz, Karin Leandersson · 2016 · Oncotarget
  91. The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
    Chunwan Lu, Priscilla S. Redd, Jeffrey R. Lee, Natasha M. Savage, Kebin Liu · 2016 · OncoImmunology
  92. Persistent Inflammation, Immunosuppression and Catabolism Syndrome
    Juan C. Mira, Scott C. Brakenridge, Lyle L. Moldawer, Frederick Alan Moore · 2017 · Critical Care Clinics
  93. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
    Jiaqiao Fan, Mengfei Wang, Hailong Chen, Dong Shang, Jugal Kishore Das, Jianxun Jim Song · 2020 · Molecular Cancer
  94. Chronic inflammation, cancer development and immunotherapy
    Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, Xiao Yang, Yuchen Gao, Mei Li, Hongyan Yang, Tongzheng Liu, Hui Tang · 2022 · Frontiers in Pharmacology
  95. Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
    Rachel A. Burga, Mitchell Thorn, Gary R. Point, Prajna Guha, Cang T. Nguyen, Lauren A. Licata, Ronald P. DeMatteo, Alfred Ayala, N. Joseph Espat, Richard Paul Junghans et al. · 2015 · Cancer Immunology Immunotherapy
  96. The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
    Laura Raccosta, Raffaella Fontana, Daniela Maggioni, Claudia Lanterna, Eduardo J. Villablanca, Aida Paniccia, Andrea Giovanni Musumeci, Elena Chiricozzi, Maria Letizia Trincavelli, Simona Daniele et al. · 2013 · The Journal of Experimental Medicine
  97. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
    Chiara Agrati, Alessandra Sacchi, Veronica Bordoni, Eleonora Cimini, Stefania Notari, Germana Grassi, Rita Casetti, Eleonora Tartaglia, Eleonora Lalle, Alessandra D’Abramo et al. · 2020 · Cell Death and Differentiation
  98. Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients
    Wen-chao Wu, Hong-Wei Sun, Hai-Tian Chen, Jing-lin Liang, Xing-juan Yu, Chong Wu, Zi-Lian Wang, Li-Min Zheng · 2014 · Proceedings of the National Academy of Sciences of the United States of America
  99. Thyroid cancer and inflammation
    Valentina Guarino, Maria Domenica Castellone, Elvira Avilla, Rosa Marina Melillo · 2009 · Molecular and Cellular Endocrinology
  100. New insights into chronic inflammation-induced immunosuppression
    Julia Kanterman, Moshe Sade-Feldman, Michal Baniyash · 2012 · Seminars in Cancer Biology